Varian Receives Investigational Device Exemption (IDE) for Flash Technology Clinical Trial, FAST-02

- FAST-02 represents a key milestone in the development of Flash therapy - Flash therapy delivers radiation at ultra-high dose rates in typically less than one second and is capable of being over 100 times faster compared to conventional radiation therapy PALO ALTO, Calif., June 27, 2022...

Click to view original post